Clinical Trial Update: Study Comparing Bivalirudin Versus Heparin in Neonatal and Pediatric ECMO [Phase 4]

View source ↗

Summary

A Phase 4 study comparing bivalirudin versus heparin in neonatal and pediatric patients on ECMO has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Extracorporeal Membrane Oxygenation Complication

Drugs mentioned

• Bivalirudin (bivalirudin)
• Heparin (unfractionated heparin)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Extracorporeal Membrane Oxygenation Complication, Pediatric ALL | Phase 4 | Status: COMPLETED | Results posted: 2023-01-31